Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Inspira Technologies Oxy BHN ( (IINN) ) is now available.
On March 31, 2026, Inspira Technologies announced it had terminated its at-the-market sales agreement with A.G.P./Alliance Global Partners and its Standby Equity Purchase Agreement with YA II PN, Ltd., confirming there are no outstanding obligations or further advances under either facility. The move underscores management’s focus on a more disciplined capital structure as the company streamlines operations and positions its respiratory and blood-monitoring technologies for the next strategic phase, with implications for how it funds growth in the competitive MedTech and life-support markets.
The most recent analyst rating on (IINN) stock is a Hold with a $0.38 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.
The score is driven primarily by very weak financial performance (minimal/unstable revenue, sustained losses, and heavy cash burn) and bearish technical conditions (price below all key moving averages with negative MACD). Valuation provides limited support because the company is loss-making (negative P/E) and offers no dividend yield.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is a commercial-stage medical device company focused on advanced respiratory support and real-time blood monitoring solutions. Its FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO procedures abroad, and underpins development of the INSPIRA ART500, while the HYLA platform targets continuous, non-invasive blood monitoring within the life-support MedTech space.
Average Trading Volume: 604,897
Technical Sentiment Signal: Sell
Current Market Cap: $17.18M
Find detailed analytics on IINN stock on TipRanks’ Stock Analysis page.